PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home »

Psychiatric Times. Vol. 24 No. 7
Pages: 1  2  
Next
 

Methamphetamine Abuse: Consequences and Treatment

By Richard Rawson, PhD and Walter Ling, MD | June 1, 2007
Dr Rawson and Dr Ling are professors-in-residence in the Jane and Terry Semel Neuropsychiatric Institute of the David Geffen School of Medicine at the University of California, Los Angeles. Both authors report they have no conflicts of interest to disclose regarding the subject matter of this article.

Methamphetamine (MA) abuse is not a new problem in the United States, but the current epidemic is more widespread and presents with more pernicious consequences than in the past. MA, frequently called "speed," "crystal," "crank," "ice," or "tina," is a potent psychostimulant that can be swallowed in pill form or administered via intranasal, intravenous, or smoking route.

Epidemiologic data on the extent and consequences of MA use among increasingly involved populations—women, men who have sex with men, rural residents, and youths—indicate a need for additional efforts to effectively treat persons who use MA and those with problems related to MA use. Recent research has influenced the way we think about MA and the related medical consequences of its use. For example, neuroimaging research and new information on the cellular mechanisms of MA's action indicate new targets for the development of pharmacotherapies. While pharmacotherapy research is still in a formative stage, behavioral therapies that have been developed for the treatment of stimulant use disorders have considerable empiric support.

EPIDEMIOLOGY
Geographic spread

In the late 1960s, MA became known as a dangerous drug, creating substantial health threats to persons who used it and prompting the drug prevention slogan "speed kills." During the late 1970s and early 1980s, MA use in the United States was, for the most part, limited to several cities in California (primarily San Francisco and San Diego), since the primary manufacturers and suppliers of MA at the time were members of Hells Angels and other motorcycle gangs that were headquartered in California.1

In the mid-1980s, MA use escalated dramatically in Honolulu as "ice," a smokable form of the drug, was imported to the island from the Philippines.2 In the 1990s, MA spread throughout the western states and began to surface in substantial amounts in the Midwest (eg, Iowa and Missouri).3

Today, MA has emerged as one of the most dangerous "homegrown" drugs in the country, and its use and dependence pose significant public health challenges.4 MA is the most widely used illicit drug in the world after cannabis,5 and it has become established as the most dominant drug problem in many western and midwestern states, severely impacting rural and suburban areas, as well as small to mid-sized cities.

MA's availability and use have migrated from the western states to mid-America and the southeastern states.6 In 2003, 14 states cited more admissions to substance abuse treatment programs resulting from MA use than from heroin and cocaine use combined; nationally, admissions related to MA use increased 10% between 2002 and 2003 (from 105,754 to 116,604).7

High-risk populations

Women use MA at rates almost equal to those of men. While the use of other major illicit drugs is characterized by ratios such as 3:1 (heroin) or 2:1 (cocaine) for men to women, in many large data sets, the ratio for persons who use MA approaches 1:1. Surveys among women suggest that they are more likely than men to be attracted to MA for reasons such as weight loss and for the control of symptoms of depression. More than 70% of women who use MA report histories of physical and sexual abuse, and women are more likely than men to present for treatment of MA abuse with greater psychological distress.8

MA use is also associated with high-risk sexual behaviors, which has been shown to be a major factor in HIV transmission among men who have sex with men.9 Research by Shoptaw and colleagues10 showed that MA use poses the biggest threat of producing a renewed spread of HIV in the gay community because of the increase in high-risk sexual behaviors. The researchers have developed treatment programs for this group that have shown the successful treatment of MA dependence to be an extremely effective HIV prevention strategy.

There appears to be an increase in MA use among adolescents in some parts of the country, particularly on the West Coast. Phoenix House, a large treatment center for adolescents in Southern California, reported that MA use accounted for almost half of the center's admissions in 200511; there was particular concern in the center regarding MA use among young women.

In another report on MA use among adolescents, 63% of girls who were admitted to substance abuse treatment received a primary diagnosis of MA abuse/dependence while only 36% of boys received MA abuse/dependence as a primary diagnosis.12

Acute and Chronic Effects

The euphoric feelings (described as a "high" or "rush") that accompany the use of MA appear to be the result of dopamine(Drug information on dopamine) release in the reward/pleasure centers of the brain. The timing and intensity of such stimulant effects depend largely on the drug's route of administration. The effects of the drug are almost instantaneous when it is smoked or injected.

Conversely, it takes about 5 minutes after snorting MA or 20 minutes after ingesting it for the onset of such effects to occur. The half-life of MA is about 8 to 12 hours, and the acute effects of MA occur during this period.

Immediate physiological changes associated with MA use are similar to those that are produced in the fight-or-flight response: that is, increased blood pressure, body temperature, heart rate, and respiration rate. Even small doses of MA can increase wakefulness, attention, and physical activity and can decrease fatigue and appetite.

Negative physical effects of MA use typically include hypertension, tachycardia, headaches, cardiac arrhythmia, and nausea; the psychological impact is manifested by increased anxiety, insomnia, aggressive and violent tendencies, paranoia, and visual and auditory hallucinations. High doses can elevate body temperature to dangerous and sometimes lethal levels, causing convulsions, coma, stroke, vegetative states, and death.

In persons who use MA for prolonged periods, tolerance for the drug frequently develops, along with escalating dosage levels and dependence. Persons who chronically use MA can be anxious and exhibit violent behavior, confusion, and insomnia, which is a result of the direct effects of the drug plus the consequences associated with sleep deprivation, since persons who use MA often report sleeplessness for days and even weeks. When they are in a state of prolonged MA use and sleep deprivation, users commonly experience a number of psychotic features, including paranoia, auditory hallucinations, mood disturbances, and delusions. One of the most regularly reported features associated with MA use is "formication," the sensation of insects creeping on the skin. The paranoia that accompanies MA use can result in homicidal or suicidal thoughts.

In a recent sample of MA users who entered treatment in the Midwest, Hawaii, and California, the rate of hepatitis C was 22%. Of those administering MA via injection, 45% tested positive for hepatitis C.13 Clearly, there needs to be a stronger effort to inform persons about behaviors that expose them to hepatitis C (through blood-to-blood transfers) and to treat and prevent MA use and abuse. See the Table for a summary of MA's adverse effects.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





  • Rawson RA, Marinelli-Casey P, Anglin MD, et al. A multisite comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708-717.
  • Roll JM, Petry NM, Stitzer ML, et al. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry. 2006;163:1993-1999.


 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • The Moral Struggles of Practicing Psychiatrists
  • Developmental Psychopathology Comes of Age
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Experts Discuss Changes, Updates in DSM-5
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • You Are—And Your Mood Is—What You Eat
  • Grief and Depression: The Sages Knew the Difference
  • Experts Discuss Changes, Updates in DSM-5
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • The Psychiatrist and the Slot Machine
  • The Role of Biological Tests in Psychiatric Diagnosis
  • You Are—And Your Mood Is—What You Eat
  • Experts Discuss Changes, Updates in DSM-5
  • The Paradox of Choice: When More Medications Mean Less Treatment
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Grief and Depression: The Sages Knew the Difference
  • Psychiatry and the Myth of “Medicalization”
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • NIMH vs DSM 5: No One Wins, Patients Lose
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • Experts Discuss Changes, Updates in DSM-5
  • The Role of Biological Tests in Psychiatric Diagnosis
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Refinements in ECT Techniques
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
Click here to subscribe to our newsletter
 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry
 
SearchMedica SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Display
Evidence on Display
Guidelines on Display
Patient Education on Display
Clinical Trials on Display
Practical Articles on Display
Research and Reviews on Display
All "Display" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy